ESC 365 - Is regional wall motion abnormality on screening echocardiography prior to trastuzumab therapy a factor influencing left ventricular function?

EAPC Premium Access

Is regional wall motion abnormality on screening echocardiography prior to trastuzumab therapy a factor influencing left ventricular function?

Session: Poster Session I - Thursday 08:30 - 18:00 - Risk factors: others_Part 2

Topic: Imaging, other

Speaker: Doctor K. Bhamidipati (Prescot, GB)

Event: EuroPrevent 2017

Congress Presentation

Add to my library

About the speaker

Doctor Kalyan Ram Bhamidipati

Whiston Hospital, Prescot (United Kingdom of Great Britain & Northern Ireland)

0 follower

14 more presentations in this session

Risk factors: others_Part 2 - Poster discussant:.

Red blood cell distribution width & myocardial scar burden in coronary artery disease

Speaker: Doctor C. Magri (Msida, MT)

Prevalence of coronary artery and thoracic aorta calcification detected incidentally on computed tomography chest imaging in a tertiary referral center in the middle east

Speaker: Doctor A. Marzaro (Beirut, LB)

Body composition and quality of life in patients with peripheral arterial disease

Speaker: Doctor A. Horina (Graz, AT)

The crucial role of cardiac magnetic resonance in focal myocarditis

Speaker: Doctor V. Lisignoli (Rome, IT)

Access the full session

Poster Session I - Thursday 08:30 - 18:00 - Risk factors: others_Part 2

Speakers: Doctor K. Bhamidipati, Doctor C. Magri, Doctor A. Marzaro, Doctor A. Horina, Doctor V. Lisignoli

About the event

EuroPrevent 2017

6 April - 8 April 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources